Total Liabilities Equity - Devyser Diagnostics AB (STO:DVYSR) - Alpha Spread
D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 117.5 SEK 0.43% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Total Liabilities & Equity Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Total Liabilities & Equity
kr510.1m
CAGR 3-Years
90%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Liabilities & Equity
kr2.3B
CAGR 3-Years
7%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Liabilities & Equity
kr752.6m
CAGR 3-Years
22%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Liabilities & Equity
kr16.9B
CAGR 3-Years
89%
CAGR 5-Years
54%
CAGR 10-Years
42%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Liabilities & Equity
kr73.2B
CAGR 3-Years
17%
CAGR 5-Years
19%
CAGR 10-Years
28%
BioArctic AB
STO:BIOA B
Total Liabilities & Equity
kr1.2B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Total Liabilities & Equity?
Total Liabilities & Equity
510.1m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Total Liabilities & Equity amounts to 510.1m SEK.

What is Devyser Diagnostics AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
60%

Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Devyser Diagnostics AB have been 90% over the past three years , 60% over the past five years .

Back to Top